|
WO2021050994A1
|
|
Heterobicyclic carboxamides and uses thereof
|
|
US2020306218A1
|
|
Ophthalmic composition for treating dry eye and symptoms thereof
|
|
US2020306182A1
|
|
Pharmaceutical compositions for treating ocular diseases or disorders
|
|
WO2020176579A1
|
|
Thienyl cyclopropyl-amino-isoquinolinyl amide compounds
|
|
US2020247760A1
|
|
Compounds, Compositions and Methods for Treatment of Myopia
|
|
AU2019337703A1
|
|
Aryl cyclopropyl-amino-isoquinolinyl amide compounds
|
|
WO2020047496A1
|
|
Isoquinoline-steroid conjugates and uses thereof
|
|
AU2019245390A1
|
|
Mono-(acid) salts of 6-aminoisoquinolines and uses thereof
|
|
CA3093963A1
|
|
Amino-benzoisothiazole and amino-benzoisothiadiazole amide compounds
|
|
KR20190135027A
|
|
Aryl Cyclopropyl-amino-isoquinolinyl Amide Compound
|
|
AU2017321980A1
|
|
Implant applicators
|
|
AU2017319520A1
|
|
Ophthalmic compositions
|
|
CN109640971A
|
|
Beta-amino isoquinolyl amide compound
|
|
US9840468B1
|
|
Methods for the preparation of 6-aminoisoquinoline
|
|
KR20180044839A
|
|
Methods of administering implant implants and implants
|
|
CN108601355A
|
|
The method for preparing kinase inhibitor and its intermediate
|
|
US9643927B1
|
|
Process for the preparation of kinase inhibitors and intermediates thereof
|
|
CN110396085A
|
|
Combination therapy
|
|
CA2798084A1
|
|
Drug delivery devices for delivery of ocular therapeutic agents
|
|
AU2010241996A1
|
|
Dual mechanism inhibitors for the treatment of disease
|
